Tze Ning Hiew

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 8

Top Topics

Emergency Department

Pulmonary Fibrosis

Top Venues

Molecular pharmaceutics

The AAPS journal

Pharmaceutical development and technology

This page only lists publications with an associated author ORCID identifier.

Publications

Wenhao Wang, Ziqiao Zhong, Zhengwei Huang, Tze Ning Hiew, Ying Huang, Chuanbin Wu, Xin Pan
Nanomedicines for targeted pulmonary delivery: receptor-mediated strategy and alternatives. Nanoscale (2024)
Wenhao Wang, Ziqiao Zhong, Zhengwei Huang, Tze Ning Hiew, Ying Huang, Chuanbin Wu, Xin Pan
Nanomedicines for targeted pulmonary delivery: receptor-mediated strategy and alternatives. Nanoscale 16 (6) (2024)
Tze Ning Hiew
A Pharmaceutical Scientist's Journey: My Path to an Academic Career. Molecular pharmaceutics (2024)
Wenhao Wang, Ziqiao Zhong, Zhengwei Huang, Tze Ning Hiew, Ying Huang, Chuanbin Wu, Xin Pan
Nanomedicines for targeted pulmonary delivery: receptor-mediated strategy and alternatives. Nanoscale 16 (6) (2024)
Hongyi Ouyang, Soon Jun Ang, Zong Yang Lee, Tze Ning Hiew, Paul Wan Sia Heng, Lai Wah Chan
Effect of drug load and lipid-wax blends on drug release and stability from spray-congealed microparticles. Pharmaceutical development and technology (2022)
Dana E Moseson, Isaac D Corum, Andres Lust, Kevin J Altman, Tze Ning Hiew, Ayse Eren, Zoltan K Nagy, Lynne S Taylor
Amorphous Solid Dispersions Containing Residual Crystallinity: Competition Between Dissolution and Matrix Crystallization. The AAPS journal 23 (4) (2021)
Tze Ning Hiew, Dmitry Y Zemlyanov, Lynne S Taylor
Balancing Solid-State Stability and Dissolution Performance of Lumefantrine Amorphous Solid Dispersions: The Role of Polymer Choice and Drug-Polymer Interactions. Molecular pharmaceutics (2021)
Natalia Veronica, Tze Ning Hiew, Celine Valeria Liew, Paul Wan Sia Heng
Insights into the Moisture Scavenging Properties of Different Types of Starch in Tablets Containing a Moisture-Sensitive Drug. Molecular pharmaceutics 17 (12) (2020)